URGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Also see: URGN Shares Outstanding History and URGN YTD Return |
URGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Also see: URGN Shares Outstanding History and URGN YTD Return |
URGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
+22.51% CAGR Mouse over chart for data details
|
URGN Stock Price Chart |
About UroGen Pharma Ltd |
UroGen Pharma is a biotechnology company focused on developing and commercializing solutions that treat urothelial and specialty cancers. Co. has developed RTGel® reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based technology that has the potential to improve therapeutic profiles of existing drugs. Co.'s Jelmyto® (mitomycin) for pyelocalyceal solution, and its UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer, respectively. We show 22 historical shares outstanding datapoints in our URGN shares outstanding history coverage, used to compute URGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing URGN market cap history over the course of time is important for investors interested in comparing URGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of URGN versus a peer is one thing; comparing URGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like URGN can fluctuate over the course of history. With this page we aim to empower investors researching URGN by allowing them to research the URGN market cap history. |
URGN Current Stock Quote |
Free URGN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
URGN Share Performance |
Market Cap Peers |
UroGen Pharma (URGN) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
UROV Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.